Latest News
Genelux Corporation
- Here's Why We're A Bit Worried About Genelux's (NASDAQ:GNLX) Cash Burn Situation
- Genelux gains abstract spot at SITC26 to present VIRO-25 clinical trial design
- Genelux Corporation (GNLX) Slips 1.77% to $2.50, Drifting Toward Near-Term Support - Volume Gap
- Genelux Corporation (GNLX) Slips 1.77% to $2.50, Drifting Toward Near-Term Support - Sector ETF Flow
- Genelux Corporation (GNLX) Slips 0.40% to $2.52 as Shares Hold Above Near-Term Support - ETF AUM Growth
Headlines from the last 30 days, linking to the original publishers. See all market news →